{
  "symbol": "AAREYDRUGS.NS",
  "period": "quarterly",
  "data": [
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2024-06-30",
      "quarter": "Q2 2024",
      "fiscal_year": 2024,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2024-09-30",
      "quarter": "Q3 2024",
      "fiscal_year": 2024,
      "revenue": 1051436000.0,
      "gross_profit": 62419000.0,
      "operating_income": 32336000.0,
      "ebitda": 37438000.0,
      "net_income": 15965000.0,
      "diluted_eps": null,
      "total_assets": 2745281000.0,
      "total_liabilities": 1389369000.0,
      "total_equity": 1355912000.0,
      "total_debt": 386502000.0,
      "cash_and_equivalents": 14897000.0,
      "current_assets": 2513499000.0,
      "current_liabilities": 1384460000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": 0.28504947223713634,
      "current_ratio": 1.815508573739942,
      "operating_margin": 3.0754130541469,
      "net_profit_margin": 1.518399598263708,
      "roe": 1.1774362938007776,
      "roa": 0.5815433829906665,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 3.560654191030172,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2024-12-31",
      "quarter": "Q4 2024",
      "fiscal_year": 2024,
      "revenue": 1337886000.0,
      "gross_profit": 33997000.0,
      "operating_income": 16205000.0,
      "ebitda": 28805000.0,
      "net_income": 7180000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 1.211239223670776,
      "net_profit_margin": 0.5366675486551171,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 2.153023501254965,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 1063910000.0,
      "gross_profit": -27850000.0,
      "operating_income": -47584000.0,
      "ebitda": 25509000.0,
      "net_income": 4701000.0,
      "diluted_eps": null,
      "total_assets": 2905920000.0,
      "total_liabilities": 1521115000.0,
      "total_equity": 1384805000.0,
      "total_debt": 348560000.0,
      "cash_and_equivalents": 14733000.0,
      "current_assets": 2656190000.0,
      "current_liabilities": 1492061000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": 0.251703308408043,
      "current_ratio": 1.7802154201470315,
      "operating_margin": -4.4725587690688124,
      "net_profit_margin": 0.4418606837044487,
      "roe": 0.3394701781117197,
      "roa": 0.16177320779649818,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 2.3976652160427103,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2025-06-30",
      "quarter": "Q2 2025",
      "fiscal_year": 2025,
      "revenue": 1022083000.0,
      "gross_profit": 43726000.0,
      "operating_income": 12172000.0,
      "ebitda": 32541000.0,
      "net_income": 13713000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 1.1909013260175545,
      "net_profit_margin": 1.3416718603088007,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 3.1837923143228095,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2025-09-30",
      "quarter": "Q3 2025",
      "fiscal_year": 2025,
      "revenue": 841620000.0,
      "gross_profit": 36790000.0,
      "operating_income": 19497000.0,
      "ebitda": 34350000.0,
      "net_income": 10238000.0,
      "diluted_eps": null,
      "total_assets": 2939972000.0,
      "total_liabilities": 1451466000.0,
      "total_equity": 1488506000.0,
      "total_debt": 507789000.0,
      "cash_and_equivalents": 71913000.0,
      "current_assets": 2563617000.0,
      "current_liabilities": 1428500000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": 0.34114004243180746,
      "current_ratio": 1.7946216310815541,
      "operating_margin": 2.316603692878021,
      "net_profit_margin": 1.2164634870844324,
      "roe": 0.6878037441568929,
      "roa": 0.34823460903709286,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 4.081414415056677,
      "revenue_growth_yoy": -19.955185099235713,
      "ebitda_growth_yoy": -8.24830386238581
    }
  ]
}